The antimicrobial susceptibility of 64 strains of S. pneumoniae obtained from three hospitals in Porto Alegre, Brazil, isolated between 2004 and 2005, was determined, using the agar-dilution method. The prevalence of resistant (intermediate and full resistance) strains to trimethoprim/sulphamethoxazole, penicillin, tetracycline, erythromycin, chloramphenicol, and ceftriaxone were 68%, 28%, 18%, 15%, 3%, and 1%, respectively. All strains were susceptible to vancomycin. Among 18 penicillin-resistant strains, 7 were resistant to at least two other antimicrobial drugs. All erythromycin-resistant strains, except one, contained the erm(B) and/or mef(A/E) genes, with a predominance of the former. The resistance rate to penicillin and erythromycin in Porto Alegre remained stable. The combination of trimethoprim/ sulphamethoxazole should not be recommended to treat pneumococcal infections, because of the high rate of resistant strains.
INTRODUCTION
Streptococcus pneumoniae is responsible for high rates of morbidity and mortality worldwide (14) . This bacterium causes a wide range of pathologies such as pneumonia, meningitis, otitis media, bacteraemia, and other less-frequent infections such as endocarditis and arthritis (5) . Pneumococcal infections are treated with penicillin as the first choice drug, and erythromycin is also frequently used. From 1980, pneumococcal strains began to show a significant increase in resistance rates to penicillin, impeding the control of infections (6) . The resistance rate of S. pneumoniae varies with the locality or region studied, is influenced by the frequency and intensity of utilization, and empirical use of the antimicrobial drugs is frequent (1, 2, 4) . Because of this evolution of susceptibility of the strains, it is important to carry out constant monitoring of pneumoccocal-related infections. There are many mechanisms of resistance to antimicrobials and with macrolides, the erm(B) and mef(A/E) genes are responsible for the most-reported mechanisms of resistance to this class. The erm(B) gene is known to confer resistance to other antimicrobial classes and a high level of resistance to the macrolides (16, 20 Erythromycin-resistant strains were screened for the presence of the erm(B) and mef(A/E) genes by PCR, using primers and reaction conditions described elsewhere (9, 18) .
Amplifications were carried out in an Eppendorf thermocycler (Personal Mastercycler) using taq polymerase Invitrogen.
DNA was extracted using enzyme treatment and phenolchloroform purifications (15) . We observed a rate of tetracycline resistance below that reported in another study with Brazilian strains (32%) (7).
Seven strains showed intermediate resistance (14%, 4µg/mL), and three strains showed full resistance (4%, >8µg/mL). Of these tetracycline-resistant strains, five were multi-resistant (Table 1) . These results indicate that the empirical use of tetracycline in pneumococcal infections is limited.
With chloramphenicol, only 3% of the strains were resistant, with two fully resistant strains (8µg/mL). Similarly low percentages were also observed in Belo Horizonte, Brazil (8) and in other countries (21) .
Of the 64 strains, only 15% (N=10) showed full resistance to erythromycin (>1µg/mL). Of these resistant strains, four were susceptible to penicillin, and six were resistant ( Table 2 ).
The rate of resistance to erythromycin was slightly increased, compared to results previously obtained with strains from
Porto Alegre and other localities (2, 9) . However, these numbers are below those reported in other countries, where rates up to 80% have been observed (2, 17).
These 10 resistant strains were analyzed to explore the possibility of a relationship between the observed resistance and the presence of the erm(B) and mef(A/E) genes. Six of these strains had erm(B), two had mef(A/E), one had both genes, and one did not have either gene (Tables 1 and 2 ). With these results, the relationship of these genes to the erythromycin resistance shown by these strains was confirmed.
Strains that had erm(B) showed MICs between 2 and >8µg/mL, and those that had mef(A/E) showed MICs between 1 and 2µg/mL ( Table 2 ). Strains that had both genes showed
MICs >8µg/mL, as did the strain that lacked these genes. In 
